[
  {
    "question": "scenario of old pt. with comorbidity and polypharmacy having frequent seizures in the last 2 years best drug for him (interaction):",
    "option_a": "Lamictal",
    "option_b": "Levetiracetam",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "In elderly patients with multiple comorbidities and polypharmacy, the choice of an AED should prioritize a low potential for drug\u2013drug interactions, ease of use, and tolerability. Levetiracetam meets these criteria and is increasingly used as a first\u2010line treatment in such cases. Seizures occur due to an imbalance between excitatory and inhibitory neuronal activity. In older individuals, coexisting cerebrovascular disease and altered pharmacokinetics may lead to suboptimal seizure control. Levetiracetam acts by binding to synaptic vesicle protein 2A, modulating neurotransmitter release without significant hepatic metabolism, therefore reducing the risk of interactions. Elderly patients often have multiple comorbidities and are receiving several medications. Levetiracetam\u2019s favorable pharmacokinetic profile \u2014 with minimal protein binding and lack of cytochrome P450 involvement \u2014 makes it particularly suitable in this group to maintain seizure control while minimizing adverse interactions. The diagnosis is based on clinical seizure semiology and confirmed by EEG. The key differential consideration is ensuring that other factors (e.g., metabolic disturbances, structural abnormalities) are ruled out. Polypharmacy mandates a thorough medication review to avoid potential drug interactions. First\u2010line management in a patient with multiple comorbidities and polypharmacy strongly favors AEDs with minimal drug\u2013drug interaction potential. Levetiracetam is dosed once or twice daily, is renally excreted, and does not induce or inhibit cytochrome P450 enzymes. In pregnancy and lactation, levetiracetam is considered relatively safe, though close monitoring is recommended due to potential changes in drug clearance. Option B (Levetiracetam) is the optimal choice for minimizing interactions in elderly patients on multiple medications. Option A (Lamictal) is an alternative; however, its metabolism may be affected by other medications and can require dose adjustments. The absence of other options further supports the selection of levetiracetam. \u2022 Levetiracetam is highly favored in polypharmacy settings because of its minimal interaction profile.  \u2022 Elderly patients often benefit from AEDs that have simpler dosing regimens and lower risks of adverse interactions. Recent epilepsy treatment guidelines and pharmacologic studies continue to support levetiracetam as a first\u2010line option in elderly patients due to its rapid onset, minimal pharmacokinetic interactions, and overall tolerability.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "a patient whose epileptic and on Topamax and CBZ CR patient presented with breakthrough seizures and EEG done shows epileptiform discharges and MRI showed mesial temporal sclerosis what is the cause of seizure for this patient:",
    "option_a": "missed dose of carbamazepine",
    "option_b": "missed dose of Topamax",
    "option_c": "mesial temporal sclerosis",
    "option_d": "bilateral interictal discharges",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "Temporal lobe epilepsy is commonly associated with mesial temporal sclerosis (MTS), a structural abnormality of the hippocampus that is the most frequent pathological finding in drug\u2010resistant epilepsy. In this patient, the underlying pathology (MTS) is the primary driver of his seizures. Mesial temporal sclerosis involves neuronal loss, gliosis, and atrophy of the hippocampus. These histopathological changes create an epileptogenic focus that predisposes the patient to recurrent seizures despite medical treatment. The presence of epileptiform discharges on EEG supports the existence of an active seizure focus. Patients with MTS typically suffer from focal seizures with or without secondary generalization. Breakthrough seizures in patients on anti\u2010epileptic medications (AEDs) are frequently due to the inherent resistance produced by the structural abnormality rather than noncompliance alone. Diagnosis is based on clinical history, interictal and ictal EEG findings (often showing focal or temporal lobe spikes), and characteristic MRI findings demonstrating hippocampal sclerosis. Differential diagnoses include seizure exacerbation due to missed doses or metabolic disturbances; however, imaging confirming MTS directs the diagnosis to an underlying structural abnormality. The first\u2010line management for temporal lobe epilepsy includes appropriate AEDs (e.g., carbamazepine, lamotrigine). In cases of drug resistance\u2014as defined by failure of at least two appropriately chosen and dosed medications\u2014early surgical evaluation is recommended. In patients of childbearing age or who are pregnant/lactating, careful medication selection (avoiding teratogens when possible) and folate supplementation are essential. Surgical resection (e.g., anterior temporal lobectomy) has shown good outcomes in cases of MTS. Option A (missed dose of carbamazepine) and Option B (missed dose of Topamax) represent potential precipitating factors for breakthrough seizures but do not account for the chronic structural abnormality seen on MRI. Option D (bilateral interictal discharges) does not explain a focal epileptogenic lesion. Option C correctly identifies MTS as the underlying cause of the seizures in this patient. \u2022 MTS is the most common cause of drug\u2010resistant temporal lobe epilepsy. \u2022 Structural abnormalities like hippocampal sclerosis persist as a seizure focus despite medication adjustments. \u2022 Early surgical evaluation is recommended for patients with confirmed MTS and persistent seizures. Recent guidelines from epilepsy societies emphasize the importance of early surgical evaluation in patients with mesial temporal lobe epilepsy who have failed two adequate AED trials, as surgery offers the best chance for long\u2010term seizure freedom. Advances in imaging and electrophysiology continue to support the role of MTS as a clear etiological factor.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "what\u2019s the EEG finding of JME:",
    "option_a": "3 Hz spike and wave",
    "option_b": "4 - 6Hz poly spike and wave",
    "option_c": "generalized slow wave",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Juvenile Myoclonic Epilepsy (JME) is a generalized epilepsy syndrome that typically presents during adolescence. It is characterized by myoclonic jerks, generalized tonic-clonic seizures, and sometimes absence seizures. The underlying mechanism in JME is thought to be a genetic predisposition leading to cortical hyperexcitability. The characteristic EEG finding is a pattern of generalized polyspike and wave discharges which usually occur at a frequency of 4-6 Hz. Clinically, JME patients often experience myoclonic jerks in the early morning and may have additional seizure types. These patients are sensitive to triggers such as sleep deprivation and flickering lights, which can further precipitate the generalized discharges seen on EEG. The differential diagnosis includes other generalized epilepsies. For instance, absence epilepsy typically demonstrates a 3 Hz spike-and-wave pattern, not polyspike-and-wave. Detailed history, age of onset, and EEG characteristics help distinguish JME from these conditions. First-line treatment for JME is valproate, which is highly effective. However, in women of childbearing potential, the teratogenic risk of valproate necessitates consideration of alternatives such as levetiracetam or lamotrigine. During pregnancy and lactation, medication selection must balance seizure control with fetal safety. Option A (3 Hz spike and wave) is classically seen in absence seizures rather than JME. Option B (4\u20136 Hz polyspike and wave) is the hallmark of JME on EEG and is therefore correct. Option C (generalized slow wave) is nonspecific and does not accurately describe the typical findings in JME. \u2022 JME is the most common form of generalized epilepsy beginning in adolescence. \u2022 The classic EEG finding is a 4\u20136 Hz polyspike and wave pattern. \u2022 Sleep deprivation is a common and potent trigger for seizures in JME. Recent research has reinforced the genetic basis of JME and the importance of early, accurate EEG diagnosis. Updated guidelines recommend tailored AED therapy based on patient sex and reproductive plans, especially taking into account the potential teratogenic effects of certain medications.",
    "exam_year": "2020",
    "exam_type": "Part II",
    "image_url": "page_17.png"
  },
  {
    "question": "a patient who has MTLE and on 2 AED and presented to clinic for follow up, he has around 1-2 attacks every few months what would you do next:",
    "option_a": "add a third medication",
    "option_b": "send patient for Video EEG",
    "option_c": "change nothing and give appointment for follow up in 6 months",
    "option_d": "anterior temporal lobectomy",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Patients with mesial temporal lobe epilepsy (MTLE) who continue to experience seizures despite being on two appropriately chosen AEDs are considered to have drug-resistant epilepsy. Effective presurgical evaluation is critical in these cases. MTLE is most commonly associated with mesial temporal sclerosis, where the hippocampal damage leads to a focal epileptogenic zone. In drug-resistant cases, this abnormal brain tissue consistently generates seizures despite polytherapy. Even if breakthrough seizures occur infrequently (e.g., 1-2 attacks every few months), their presence in a patient on two medications indicates that seizure control is not optimal. This situation warrants a detailed evaluation to confirm seizure origin and consider alternative management options such as surgery. The differential evaluation includes assessing for non-epileptic events, medication noncompliance, and confirming the seizure focus through prolonged video EEG recording. Video EEG monitoring is critical in correlating clinical events with EEG abnormalities and is an essential component of pre-surgical evaluation. \u2022 First-line management includes optimizing and ensuring compliance with current AED regimens. \u2022 Since the patient meets the criteria for drug-resistant epilepsy, the next recommended step is a thorough presurgical evaluation, starting with prolonged video EEG monitoring to capture typical seizure activity. \u2022 If confirmed, patients may be candidates for surgical resection (e.g., anterior temporal lobectomy). \u2022 In pregnant or lactating women, the risk\u2013benefit analysis is crucial; surgical interventions are typically deferred unless seizures are severely uncontrolled, and careful AED management is warranted to minimize fetal risk. Option A (add a third medication) is generally not recommended since adding more drugs rarely achieves seizure freedom and may increase side effects. Option B (send patient for Video EEG) is essential for confirming the seizure focus and advancing towards surgical evaluation, thus it is correct. Option C (change nothing and schedule follow-up) is inadequate given the presence of breakthrough seizures. Option D (anterior temporal lobectomy) may eventually be an option but should be considered only after a complete presurgical evaluation, including video EEG monitoring. \u2022 In drug-resistant MTLE, video EEG is the gold standard for presurgical evaluation. \u2022 Early referral for surgical evaluation improves outcomes in patients with focal epilepsy. \u2022 Breakthrough seizures, even if infrequent, in the context of MTLE warrant comprehensive re-assessment of management. Current guidelines from the International League Against Epilepsy and the American Epilepsy Society underscore the importance of early surgical evaluation in patients with drug-resistant temporal lobe epilepsy, as surgical resection offers a high likelihood of long-term seizure freedom. Recent studies support the use of video EEG monitoring as a critical tool in the accurate localization of the epileptogenic zone.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "after moderate traumatic brain injury and episode of transient global amnesia risk of seizure persist for how long?",
    "option_a": "up to 5 years",
    "option_b": "up to 10 years",
    "option_c": "up to 15 years",
    "option_d": "up to 20 years",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "After a traumatic brain injury (TBI), patients are at risk for developing post-traumatic epilepsy. The risk period after moderate TBI is prolonged and must be considered for long-term monitoring and patient counseling. Traumatic brain injury can cause neuronal injury, gliosis, and the formation of an epileptogenic focus. The process of epileptogenesis may extend over months to years as the injured brain undergoes progressive changes that predispose to seizures. Clinically, patients with moderate TBI are at higher risk for late-onset seizures, which can manifest months to years after the initial injury. Although early seizures (within the first week) are common, late seizures may develop long after the trauma, resulting in chronic epilepsy. In evaluating a patient post-TBI, it is important to differentiate early post-traumatic seizures (provoked typically within 7 days) from late post-traumatic epilepsy. Other differentials include metabolic encephalopathy and non-epileptic events. Serial EEG, imaging studies, and detailed history can help establish the diagnosis. Management includes both acute and long-term strategies. Prophylactic AEDs are sometimes used in the first week after TBI, but there is no consensus on long-term prophylaxis. Patients should be counseled about the risk of seizures, which remains elevated for years. When managing women who are pregnant or lactating, awareness of the potential teratogenicity of AEDs is fundamental, and safer alternatives should be employed when necessary. Option A (up to 5 years) underestimates the duration of increased seizure risk after moderate TBI. Option B (up to 10 years) is supported by data indicating that the risk of developing post-traumatic epilepsy remains significantly elevated for up to a decade post-injury. Options C (up to 15 years) and D (up to 20 years) overestimate the commonly accepted risk period for moderate injuries. \u2022 The risk of late post-traumatic seizures can persist for years after moderate TBI. \u2022 Late-onset post-traumatic epilepsy is typically defined as seizures occurring beyond one week after injury. \u2022 Patient counseling regarding seizure risk should include discussions of the prolonged period of vulnerability, typically up to 10 years. Recent epidemiological studies and guidelines suggest that the increased risk of epilepsy after moderate TBI can persist for up to 10 years. This evidence underscores the need for long-term follow-up and individual patient counseling regarding seizure risk, while also guiding decisions on the duration of surveillance and potential intervention.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "scenario of uncontrolled epilepsy on 2 AED asking for next:",
    "option_a": "Refer to surgery",
    "option_b": "Vagal nerve",
    "option_c": "Add AED",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Drug\u2010resistant epilepsy is defined as the failure to achieve seizure freedom after adequate trials of at least two appropriately chosen and tolerated antiepileptic drugs (AEDs). Once epilepsy is proven to be refractory, a re\u2010evaluation of the patient\u2019s candidacy for surgical intervention is warranted. In drug\u2010resistant epilepsy, the underlying epileptogenic zone may be due to structural abnormalities (e.g., mesial temporal sclerosis, focal cortical dysplasia) that lead to persistent seizure generation. Surgical resection aims to remove the epileptogenic tissue, thereby breaking the circuit that sustains seizure activity. A patient on two AEDs who continues to experience seizures despite adequate medication trials is considered to have drug\u2010resistant epilepsy. These patients are often referred for a comprehensive presurgical evaluation (including video EEG, high-resolution imaging, and neuropsychological assessment) to identify potential resectable foci. The diagnostic workup includes prolonged video EEG monitoring, MRI for lesion localization, and sometimes additional functional imaging (PET, SPECT). Differential diagnoses include non-epileptic events and multifocal onset epilepsies, but the failure of two AEDs in a clear epileptic syndrome strongly supports a drug\u2010resistant diagnosis. First-line management in drug-resistant epilepsy is a referral for surgical evaluation at a specialized epilepsy center. If a resectable focus is identified, resective surgery is considered the optimal treatment. For patients not suitable for resection, neuromodulation treatments like vagal nerve stimulation (VNS) are potential second-line therapies. In pregnancy and lactation, the risks of uncontrolled seizures are significant, so achieving seizure control is essential; surgical options must be carefully weighed in a multidisciplinary setting with obstetric input. Option A (Refer to surgery) is correct because after failure of two AEDs, current guidelines advocate for a surgical evaluation. Option B (Vagal nerve stimulation) is typically reserved for those who are not candidates for resective surgery. Option C (Add AED) is generally discouraged since adding further medications after two failures has a lower likelihood of achieving seizure remission. 1. Failure of two appropriate AED trials signifies drug-resistant epilepsy. 2. Early surgical evaluation can improve seizure outcomes. 3. A thorough presurgical workup is critical in identifying suitable surgical candidates. Recent guidelines from the ILAE and American Epilepsy Society emphasize early referral for surgery in drug-resistant epilepsy, with outcomes data supporting improved seizure control and quality of life in properly selected patients.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "young pt. With 10-year hx of focal seizures on Rx has been seizure free for 2 years best predict seizure remission:",
    "option_a": "Long duration of active disease",
    "option_b": "Short duration of seizure remission",
    "option_c": "Having one type seizure",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "Predictors of seizure remission in epilepsy include clinical factors that reflect the simplicity of the epileptogenic zone and the overall disease burden. A patient with a single seizure type tends to have a more favorable prognosis compared to those with multifocal or polymorphic seizure presentations. A singular seizure type often indicates a more localized or self-limited epileptogenic network. In contrast, polymorphic seizures can signal a more diffuse brain involvement that may be more resistant to treatment. In a young patient with a 10-year history of focal seizures who has maintained a 2-year seizure-free period, having only one type of seizure is a positive prognostic factor. This suggests a less complex seizure disorder that is more likely to remain in remission with continued management. Evaluation includes a detailed seizure history, EEG analysis, and neuroimaging to confirm the focal nature and consistency of the seizure type. Differential considerations involve other epileptic syndromes with mixed seizure types, which are generally associated with less favorable outcomes. Management in patients with prolonged remission (typically a seizure-free period of 2 years or more) involves careful consideration regarding AED withdrawal. Current guidelines suggest weighing the risks of relapse against the benefits of discontinuation. In women who are pregnant or lactating, the decision to withdraw medications should be approached with caution due to the risks associated with seizure recurrence during pregnancy. Option A (Long duration of active disease) is typically associated with a poorer prognosis. Option B (Short duration of seizure remission) is a negative predictor, as longer remission periods are more favorable. Option C (Having one type seizure) is correct because a single, consistent seizure type is indicative of an underlying focal and more manageable epileptogenic process. 1. A single seizure type is associated with a higher likelihood of long-term remission. 2. A minimum of 2 years of seizure freedom is often used as a benchmark before considering AED withdrawal. 3. Duration of active epilepsy prior to achieving remission is inversely related to prognosis. Recent studies continue to support that patients with localized epileptogenic zones and a single seizure type have a better prognosis and a higher likelihood of sustained remission, guiding decisions in AED management and potential withdrawal.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario of young pt. with absence like picture:",
    "option_a": "Frontal",
    "option_b": "temporal",
    "option_c": "parietal",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Childhood absence epilepsy (CAE) is traditionally categorized as an idiopathic generalized epilepsy. However, evolving research suggests that although the seizures appear generalized, they may originate from a localized area in the frontal cortex, which then rapidly engages thalamocortical circuits. The discharges seen in absence epilepsy are generated by abnormal oscillations within the thalamocortical network. Recent cortical focus theories propose that a hyperexcitable region in the frontal lobe initiates these characteristic 3Hz spike-wave discharges before they generalize. Clinically, absence seizures present as brief episodes of impaired consciousness with staring and subtle motor signs. The frontal cortical involvement is supported by the observation that many interictal EEGs in absence epilepsy show frontal predominance despite the generalized appearance of the discharges. Diagnosis is primarily based on the typical clinical presentation and EEG findings showing 3 Hz spike-wave discharges. Differential diagnoses include complex partial seizures (often temporal in origin) and attentional lapses, but the classic EEG pattern strongly supports CAE. First-line treatment in CAE is typically ethosuximide for seizures limited to absences, with valproate as an alternative if other seizure types are present. In pregnancy and lactation, ethosuximide is preferred over valproic acid due to the teratogenic risk associated with the latter. Ongoing monitoring and dose adjustments (if indicated) are essential during pregnancy. Option A (Frontal) is correct as current research supports a frontal cortical focus in the generation of absence seizures. Options B (Temporal) and C (Parietal) are less consistent with both clinical and electrophysiological evidence regarding absences. 1. Despite a generalized seizure pattern, a localized frontal cortical focus may initiate absence seizures. 2. EEG in CAE typically demonstrates 3 Hz spike-wave discharges with frontal predominance. 3. Ethosuximide remains the first-line treatment for uncomplicated CAE, especially in women of childbearing age. Recent neurophysiological studies and advanced imaging techniques continue to support the cortical focus theory, implicating the frontal lobe in the initiation of absence seizures. This has refined our understanding of CAE and influenced therapeutic approaches.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario with child with walking during sleep and drooling, ictal speech (not remembering):",
    "option_a": "centrotemporal spikes",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Benign childhood epilepsy with centrotemporal spikes (BECTS), also known as Rolandic epilepsy, is a common childhood epilepsy syndrome characterized by focal seizures that often occur during sleep. Typical features include orofacial motor symptoms, drooling, and sometimes speech arrest. BECTS is believed to arise from a transient, age-dependent hyperexcitability in the rolandic (centrotemporal) region. The abnormal cortical discharges manifest as centrotemporal spikes on EEG, which are considered pathognomonic for this condition. Children with BECTS may present with seizures that occur predominantly at night. Clinical features include motor phenomena such as twitching of the face, drooling, and, in some cases, brief alterations in awareness. The episodes are usually self-limited and non-progressive, with patients typically outgrowing the condition by adolescence. Diagnosis is confirmed by EEG, which typically shows centrotemporal spikes, often accentuated during sleep. The differential diagnosis includes parasomnias like sleepwalking (somnambulism), but the presence of focal motor symptoms (drooling, ictal speech), and characteristic EEG findings distinguish BECTS from other sleep disorders. BECTS is usually managed conservatively because seizures are infrequent and benign; treatment with AEDs is reserved for cases with frequent or disruptive seizures. Carbamazepine, levetiracetam, or valproate can be used if treatment is necessary. While BECTS itself is benign, care must be taken in women of childbearing potential who plan future pregnancies by choosing AEDs with better safety profiles during pregnancy and lactation. Option A (Centrotemporal spikes) is correct, as the hallmark EEG finding in BECTS is centrotemporal spikes. The absence of additional options indicates that the answer focuses on the characteristic electrophysiological pattern that confirms the diagnosis. 1. BECTS typically presents with nocturnal seizures characterized by facial motor symptoms and drooling. 2. It is an age-dependent epilepsy syndrome with a favorable prognosis, usually resolving by adolescence. 3. EEG findings of centrotemporal spikes are crucial for diagnosis. Recent studies reaffirm the benign nature of BECTS and support a conservative management approach. Advances in pediatric neuroimaging and EEG analysis have further refined diagnostic criteria, emphasizing the characteristic centrotemporal spike pattern.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Question about Landau-Kleffner syndrome (LKS):",
    "option_a": "",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Landau\u2010Kleffner syndrome (LKS) is a rare pediatric epileptic encephalopathy characterized by the acquired loss of language (aphasia) in previously normal children. It is associated with epileptiform activity, particularly with abnormal EEG findings during sleep, which disrupt normal language processing. The syndrome is thought to result from abnormal epileptiform discharges, predominantly in the temporoparietal regions that support language. These discharges \u2013 which may intensify during sleep \u2013 interfere with the development and maintenance of normal language networks. Newer studies suggest an interplay between genetic predisposition and aberrant neural network activity. Children with LKS typically present between ages 3 and 8 with a marked regression in language skills. Seizures are common (though they might be subtle), and despite often normal behavior during wakefulness, language deficits become profound. The discrepancy between relatively preserved non-language abilities and severe aphasia is a clinical hallmark. Diagnosis is based on clinical history and is supported by EEG findings that often show continuous spike-and-wave discharges during sleep. The differential diagnosis includes other forms of childhood epileptic encephalopathies and developmental language disorders. Neuroimaging is usually normal and primarily used to exclude structural lesions. Management involves antiepileptic drugs (AEDs) such as valproate or benzodiazepines, and sometimes steroids are used in refractory cases. Intensive speech and language therapy is essential for recovery. Although pregnancy and lactation issues are not directly relevant in this pediatric population, in cases where a child becomes adolescent and if AEDs are continued, choices with lower teratogenic risk (like levetiracetam) may be considered, following current epilepsy in pregnancy guidelines. Since the answer options were not provided in detail, the assumed correct option (B) likely described the characteristic features of LKS \u2013 namely, acquired aphasia in children with sleep-potentiated epileptiform activity. The marked answer aligns with the classical definition of LKS. \u2022 LKS typically presents in children between 3 and 8 years of age with a regression of previously acquired language skills.  \u2022 A key diagnostic clue is a normal awake EEG with significant abnormalities during sleep.  \u2022 Early intervention with both AEDs and speech therapy is crucial for better outcomes. Recent research emphasizes the importance of early diagnosis and intervention, including trials with steroids, newer AEDs, and even immunomodulatory treatments in refractory cases. However, speech therapy remains the cornerstone of long\u2010term management.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "A 3-year-old boy presented with developmental delay and seizure consisting of tonic seizures drop attacks and other kind of seizures EEG was done, what do you expect to find on his EEG (LGS)",
    "option_a": "3 Hz spike and wave",
    "option_b": "Epileptiform discharges less than 2Hz",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Lennox\u2013Gastaut syndrome (LGS) is a severe childhood-onset epileptic encephalopathy distinguished by multiple types of seizures (including tonic and atonic \u2018drop attacks\u2019), cognitive impairment, and a characteristic EEG pattern. LGS involves multifocal epileptogenesis with widespread cortical dysfunction. The underlying neuronal network instability leads to the manifestation of various seizure types. The EEG in LGS is noted for its slow spike-and-wave complexes, usually at a frequency below 2.5 Hz, reflecting the diffuse cortical involvement. The clinical presentation includes a mix of seizure types such as tonic, atonic (drop attacks), and atypical absence seizures, accompanied by developmental delay. The drop attacks can lead to injuries, making the accurate diagnosis critical. Observing the specific EEG pattern helps in differentiating LGS from other childhood epilepsy syndromes. The diagnostic work-up includes a detailed history, video-EEG monitoring, and neuroimaging to exclude other structural causes. Differentiation from typical childhood absence epilepsy\u2014which shows a 3 Hz spike-and-wave pattern\u2014is based on the slower frequency in LGS (<2 Hz as mentioned in option B) and a more complex seizure semiology. Management involves a tiered approach: First-line treatments typically include valproate, lamotrigine, or benzodiazepines. Adjunctive therapies like rufinamide or clobazam may be added, and in refractory cases, non-pharmacologic therapies (ketogenic diet, vagus nerve stimulation, or surgical options) should be considered. In women of childbearing potential, selecting AEDs with lower teratogenic risk (such as lamotrigine or levetiracetam) is advised, and similar considerations apply if a patient becomes pregnant or is lactating. Option A (3 Hz spike-and-wave) is characteristic of childhood absence epilepsy, not LGS. Option B is correct; LGS is associated with slow (<2 Hz) spike-and-wave discharges. Options C and D were not provided but the marked answer (B) aligns with the classical EEG pattern in LGS. \u2022 LGS is a multifaceted epilepsy syndrome with a characteristic slow spike-and-wave EEG pattern.  \u2022 Differentiation from absence epilepsy is crucial: absence seizures show a classic 3 Hz pattern.  \u2022 LGS is often refractory to treatment, emphasizing the need for multi-modality management. Recent clinical guidelines stress individualized treatment plans, with emerging evidence supporting the ketogenic diet and novel AEDs in managing drug-resistant epilepsy. The emphasis on long-term developmental outcomes continues to drive aggressive early management.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Long scenario of pt. With risk factor for stroke had hx of dizziness went to ER given meclizine then second day developed fluctuation LOC then weakness then posturing in the ambulance. CT brain attached showing hyperdense basilar artery and lt. Temporal hypodensity what to do: (picture of basilar artery stroke vs seizure 2nd to stroke not sure)",
    "option_a": "IV AED",
    "option_b": "Acyclovir",
    "option_c": "Thrombolytics",
    "option_d": "Thrombectomy or IV AED if patient seizing",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Epilepsy",
    "explanation": "Acute basilar artery occlusion represents a neurovascular emergency. In this scenario, the patient\u2019s clinical evolution \u2013 including fluctuating level of consciousness, posturing, and focal neurological deficits \u2013 alongside imaging findings (a hyperdense basilar artery and focal hypodensity) point toward an ischemic stroke with possible secondary seizure activity. Occlusion of the basilar artery results in ischemia of the brainstem and posterior circulation territories. The subsequent infarction can lead to neuronal irritation and secondary seizures. The presence of a hyperdense artery on CT is an early sign of thromboembolism. In addition, postictal phenomena or active seizure activity may contribute to altered mental status and posturing. Patients with basilar strokes can present with varied symptoms including dizziness, fluctuating levels of consciousness, cranial nerve deficits, or posturing due to brainstem involvement. Seizures may occur as a secondary phenomenon in the setting of acute ischemia, necessitating a management approach that addresses both the vascular occlusion and seizure control. Diagnosis is primarily based on clinical presentation and neuroimaging. CT scans identifying a hyperdense basilar artery and hypodense areas in the brain parenchyma are key findings. Differential diagnoses include hemorrhagic stroke, posterior reversible encephalopathy syndrome, or even a seizure with postictal changes. Definitive diagnosis relies on correlating imaging with clinical history, and additional vascular imaging (CTA/MRA) may be required. The current guideline-recommended management involves emergent revascularization. Mechanical thrombectomy is favored for large vessel occlusions, especially if the patient presents outside the narrow window for IV thrombolysis, or if imaging suggests salvageable brain tissue. If the patient is actively seizing, prompt administration of IV AEDs is indicated. In pregnant or lactating patients, while emergent imaging (with appropriate shielding) and stroke interventions are necessary, the choice of AED (e.g., lorazepam or levetiracetam) should consider their comparatively lower teratogenic risks. Option A (IV AED) alone does not address the critical vascular occlusion. Option B (Acyclovir) is used in suspected herpes encephalitis and is inappropriate here. Option C (Thrombolytics) might be considered if within the therapeutic window; however, basilar occlusions are often better managed with thrombectomy. Option D appropriately encompasses the dual possibility: pursuing thrombectomy for basilar stroke or administering IV AED if the patient is exhibiting seizure activity; thus, it is the best choice. \u2022 Basilar artery occlusion is a life\u2010threatening stroke that requires rapid revascularization.  \u2022 A hyperdense artery sign on CT is a key early imaging marker.  \u2022 In stroke patients, posturing may represent either severe brain injury or seizure activity, necessitating a dual management approach. Recent randomized trials and meta-analyses have supported the use of mechanical thrombectomy in posterior circulation strokes, sometimes extending beyond traditional thrombolytic windows. Concurrently, guidelines recommend rapid seizure management in acute stroke when clinically warranted, with ongoing studies exploring the optimal AED regimens in such scenarios.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Vague scenario about localization they mention posturing and nocturnal seizures:",
    "option_a": "SMA",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "The scenario points toward a localization issue in epilepsy where patients experience nocturnal seizures accompanied by abnormal posturing. Such features are often seen in frontal lobe epilepsies, particularly those emanating from the supplementary motor area (SMA), which plays a key role in motor planning and execution. The SMA is part of the medial frontal cortex and is involved in initiating and coordinating motor activity. Abnormal hyperexcitability in this region can result in seizures marked by abrupt motor phenomena, including posturing. Seizures from the SMA often occur during sleep, potentially due to reduced cortical inhibition at night. Clinically, patients with SMA seizures may present with brief, often stereotyped motor events that occur predominantly at night (nocturnal seizures). The motor manifestations, such as postural changes or tonic movements, help localize the seizure focus to the medial frontal region, specifically the SMA. Diagnosis relies on correlating clinical semiology with video-EEG monitoring. Differential diagnoses include other frontal lobe seizure syndromes, parasomnias, and psychogenic non-epileptic seizures. Detailed EEG studies, possibly with sleep recordings, are essential to confirm the SMA involvement. First-line management of focal seizures arising from the SMA generally involves AEDs such as lamotrigine, levetiracetam, or carbamazepine. For patients with drug-resistant epilepsy, epilepsy surgery or neuromodulation (e.g., vagus nerve stimulation) may be considered. In pregnant or lactating women, agents like lamotrigine and levetiracetam are preferred because of their better teratogenic profiles, in line with current guidelines on epilepsy management during pregnancy. Option A (SMA) is the correct localization based on the provided clinical clues of posturing and nocturnal seizures. Although the actual answer options were not fully detailed, the marked answer A fits with the understanding that the SMA is a common source of such seizure manifestations. Other potential options (if provided) would likely refer to regions not typically associated with these specific semiological features. \u2022 Frontal lobe epilepsies, particularly those involving the SMA, often manifest with nocturnal seizures and prominent motor phenomena.  \u2022 The SMA is responsible for initiating movement; abnormal activity here leads to stereotyped posturing.  \u2022 Video-EEG monitoring during sleep is particularly valuable for localizing these seizures. Recent studies emphasize the heterogeneity of frontal lobe epilepsies and the role of advanced neuroimaging and electrophysiological techniques in precisely localizing the epileptogenic focus. There is a growing body of evidence supporting tailored AED therapy and, in selected patients, surgical intervention for refractory SMA seizures.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "a patient with JME on a single AED and had been seizure free for the last 2 years. they came to clinic and ask about possibility of stopping the medication, what would you do?",
    "option_a": "stop the AED (or start tapering?",
    "option_b": "order EEG to aid in the management",
    "option_c": "educate the patient on the need of life long medication for JME",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "Juvenile Myoclonic Epilepsy (JME) is a subtype of genetic generalized epilepsy characterized by myoclonic jerks, typically in the morning, sometimes with generalized tonic\u2010clonic seizures and occasionally absences. The core concept is that JME is a chronic, lifelong condition that generally requires long\u2010term antiepileptic therapy. JME involves abnormal thalamocortical circuitry leading to a predisposition for seizures. The genetic predisposition, along with disturbances in ion channel function, results in the propensity for generalized, bilateral synchronous discharges. Despite a period of seizure freedom, the underlying neurophysiological abnormality remains, making cessation of AEDs associated with a high risk of relapse. Patients with JME typically present in adolescence with myoclonic jerks (often after waking), and have a risk for generalized tonic-clonic seizures. Even if seizure free for a couple of years on a single antiepileptic drug (AED), the nature of JME is such that withdrawal of the medication can result in recurrence, especially as triggers (like sleep deprivation and stress) may contribute. Diagnosis is based on clinical history and EEG findings showing generalized polyspike and slow-wave discharges. Differential diagnoses include juvenile absence epilepsy and other forms of generalized epilepsy. The decision to discontinue AED therapy should incorporate not only the duration of seizure freedom but the nature of the epilepsy syndrome. According to established guidelines, patients with JME require long-term, often lifelong, seizure prophylaxis. First-line medications include valproate (especially in males), lamotrigine, and levetiracetam. Decisions on AED discontinuation in JME are approached very cautiously, even after 2 years of seizure freedom. In women, medication choices are affected by teratogenic risks, but in general, counseling in JME emphasizes that lifetime treatment is often necessary. No additional testing (like a routine EEG) is usually needed solely to make the decision about medication discontinuation. Option A (stop/taper AED) is inappropriate given the high relapse risk inherent to JME. Option B (order EEG) is not considered essential for the decision process in a well-controlled JME patient. Option C (educate the patient on the need for lifelong medication) is correct because it directly addresses the chronic nature of JME and the high likelihood of relapse if therapy is stopped. 1. JME is a lifelong epilepsy syndrome with a high relapse rate upon tapering AEDs, even after a seizure-free period. 2. The typical EEG pattern for JME is generalized polyspike and slow-wave discharges. 3. Counseling should emphasize adherence due to potential triggers such as sleep deprivation or alcohol use. Recent guidelines and literature reiterate that withdrawal of AEDs in JME, even after 2 years of seizure freedom, poses a high risk for relapse. Lifelong therapy is thus recommended, and patient education is essential to ensure adherence and understanding of the chronic nature of JME.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "A neonate developed seizures within 24 hours of birth and have high bilirubin what would be the most affected area on MRI:",
    "option_a": "Thalamus",
    "option_b": "Caudate",
    "option_c": "GP",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "Kernicterus, or bilirubin-induced neurologic dysfunction, is a severe complication of neonatal hyperbilirubinemia. The condition is characterized by bilirubin deposition in specific areas of the brain, most notably within the basal ganglia. In neonates, elevated unconjugated bilirubin can cross the immature blood-brain barrier and deposit in regions with high lipid content. The globus pallidus is particularly susceptible. This deposition leads to neuronal injury and subsequent movement disorders, auditory deficits, and other neurological impairments. Neonates with high bilirubin levels may initially present with lethargy or feeding difficulties, and later on develop movement disorders, hypotonia, or episodes of seizures. On MRI, the globus pallidus typically shows abnormal signal intensity indicative of bilirubin deposition. Recognizing these imaging findings is crucial for diagnosing kernicterus. Diagnosis involves correlating clinical features with laboratory values (elevated total serum bilirubin) and neuroimaging findings. Differential diagnoses include hypoxic-ischemic encephalopathy and metabolic disorders; however, the specific pattern of globus pallidus involvement on MRI alongside a history of severe hyperbilirubinemia supports the diagnosis of kernicterus. The primary focus is prevention through early detection and treatment of neonatal jaundice using phototherapy and, when indicated, exchange transfusion. There is no specific treatment for established kernicterus aside from supportive care. In terms of pregnancy and lactation, prevention is key; maternal factors that may lead to neonatal hyperbilirubinemia should be addressed during prenatal care. Option A (Thalamus) and Option B (Caudate) are not the typical sites of bilirubin deposition. Option C (Globus pallidus) is the most commonly affected area in kernicterus, making it the correct answer. 1. Kernicterus is preventable with prompt treatment of neonatal hyperbilirubinemia. 2. The globus pallidus is the hallmark region for bilirubin deposition in kernicterus. 3. Early identification and management of jaundice are critical in neonatal care. Recent studies and guidelines emphasize aggressive management of neonatal hyperbilirubinemia to prevent kernicterus. Modern protocols and improved neonatal screening have significantly reduced the incidence of this condition.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "A chid who has 2 episodes of seizure, all when he was in the train, associated with nausea and vomiting. EEG showed posterior discharges, What\u2019s the Dx?",
    "option_a": "occipital seizure.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Occipital lobe seizures are focal seizures originating from the occipital cortex, often presenting with visual symptoms and sometimes with autonomic manifestations, such as nausea and vomiting. Epileptic discharges originating in the occipital cortex can lead to disturbances in visual processing. In some children, occipital seizures may also involve autonomic networks leading to symptoms like nausea and vomiting. An EEG showing posterior (occipital) spikes or discharges helps localize the seizure focus. In children, occipital seizures may present with visual hallucinations, illusions, or transient blindness. Autonomic symptoms, such as nausea and vomiting, can also accompany these seizures. The specific trigger, such as a particular environment (e.g., riding a train with visual stimulation or motion), may precipitate seizures in susceptible children. Diagnosis is based on a comprehensive history, EEG findings (showing occipital or posterior discharges), and correlation with clinical events. Differential diagnoses include migraine with aura (which can also cause visual disturbances and nausea) and Panayiotopoulos syndrome, a benign childhood occipital epilepsy with prominent autonomic symptoms. However, the presence of definitive EEG discharges in the posterior regions supports an epileptic etiology. First-line management typically involves anti-seizure medications that are effective in focal epilepsies, such as carbamazepine, levetiracetam, or valproate. For children, dosing and drug selection must consider age-specific factors. If autonomic symptoms are predominant, supportive care during seizures is also necessary. There are no specific pregnancy or lactation considerations in a child; however, parental counseling and education are essential. Option A (occipital seizure) is correct as it accurately reflects the seizure origin supported by the EEG findings. Other potential options, such as a global or multifocal seizure disorder, are less consistent with an isolated posterior discharge pattern on EEG and the specific clinical scenario provided. 1. Occipital seizures may present with both visual and autonomic symptoms in children. 2. EEG posterior discharges are a strong indicator of an occipital seizure focus. 3. Panayiotopoulos syndrome should be considered in children with autonomic symptoms and occipital EEG abnormalities. Contemporary research on childhood epilepsies supports the use of EEG patterns in localizing seizure foci, and current guidelines advocate for tailored therapy in focal epilepsy syndromes such as occipital lobe epilepsy. Recent data have elucidated the spectrum of autonomic manifestations in these children, further refining diagnostic criteria.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Male patient has migraine and siezure; what medications you will give?",
    "option_a": "valproic acid",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Valproic acid is a broad-spectrum antiepileptic drug that is effective in treating a variety of seizure types. It also has established efficacy in migraine prophylaxis, making it a preferred choice in patients who suffer from both migraines and seizures. Valproic acid works by increasing levels of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter, and by modulating sodium channels and T-type calcium channels. This multi-faceted mechanism helps stabilize neuronal membranes and prevent the hyperexcitability that underlies both migraine auras and epileptic discharges. A male patient with a history of both migraine and seizure benefits from a single therapeutic agent that addresses both conditions. The dual efficacy of valproic acid makes it an attractive option, particularly because in male patients, the reproductive risks associated with valproate are not a concern as they are in women of childbearing potential. The decision to use valproic acid is based on the clinical diagnosis of both migraine (often diagnosed clinically from a history of recurrent, debilitating headaches with specific characteristics) and epilepsy (supported by seizure history and EEG findings). Differential considerations include other anti-seizure medications like topiramate, which also has migraine prophylaxis properties, but valproate remains a preferred agent in many cases, particularly where generalized seizures are involved. First-line management for a male patient with both conditions can include valproic acid due to its efficacy in seizure control and migraine prophylaxis. For female patients, particularly of childbearing age, alternative agents are often considered due to the teratogenic potential of valproate. Second-line options, if valproate is contraindicated or not tolerated, may include topiramate. In pregnancy and lactation, valproic acid is usually avoided because of the high risk of fetal malformations and neurodevelopmental issues. Option A (valproic acid) is correct because it provides dual coverage for both migraine prophylaxis and seizure management. Other options, while they may treat one condition or the other, may not offer the benefit of addressing both simultaneously, and for a male patient not concerned with teratogenic issues, valproic acid is ideally suited. 1. Valproic acid is effective for both generalized seizures and migraine prevention. 2. The use of valproate in women of childbearing potential is limited due to teratogenic risks; however, it is a preferred option in male patients. 3. A dual-diagnosis patient benefits from streamlined management with a single agent that addresses both conditions. Recent guideline updates continue to support the use of valproic acid for its dual efficacy. Although there are emerging alternatives like topiramate, especially in women, current evidence endorses valproate\u2019s role in male patients with concomitant migraine and epilepsy, with ongoing studies refining optimal dosing and long-term safety profiles.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with MTS seizure EEG showed left temporal discharges, what symptoms he has?",
    "option_a": "Left automatism",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Mesial temporal lobe epilepsy (MTLE), most commonly due to mesial temporal sclerosis (MTS), typically presents with focal seizures that may begin with an aura followed by impaired awareness and automatic behaviors. Auras in temporal lobe epilepsy often involve visceral sensations or d\u00e9j\u00e0 vu. Automatisms (such as lip smacking, hand fumbling) are common features and help in localizing the seizure onset to the temporal lobe. MTS is characterized by sclerosis and neuronal loss, particularly in the hippocampus and adjacent mesial temporal structures. This structural abnormality predisposes to abnormal, synchronous neuronal discharges. The abnormal discharges often spread within limbic and temporal networks, producing the typical aura and complex partial (focal impaired awareness) seizures, with the lateralization sometimes influencing clinical features such as language disturbance when the dominant (usually left) hemisphere is involved. Patients with left temporal lobe discharges (as shown on EEG) commonly present with features including an aura (often epigastric rising sensation) and then progress to complex partial seizures with automatisms. When the epileptogenic zone is in the dominant hemisphere, symptoms such as speech arrest or subtle language deficits may also be seen. The marked option of a left\u2010sided automatism reflects these stereotyped, involuntary behaviors seen during an ictal event. Diagnosis is based on clinical history, detailed description of the aura and automatisms, and EEG findings that localize the epileptogenic focus. MRI is used to identify MTS. Differential diagnosis includes other focal epilepsies (e.g., lateral temporal or extratemporal epilepsies) and psychogenic non\u2010epileptic events; detailed semiology and video\u2010EEG monitoring help differentiate these conditions. Initial management involves anti\u2010epileptic drugs (AEDs) tailored for focal seizures (such as carbamazepine, levetiracetam, or lamotrigine). In patients with drug\u2010responsive seizures, doses are adjusted carefully. For those who remain refractory, surgical evaluation becomes important. Pregnancy and lactation considerations are critical: many AEDs have teratogenic potential, so in women of childbearing age, monotherapy with the safest drugs at the lowest effective dose is preferred, along with folate supplementation. Option A \u2013 'Left automatism' is correct because focal seizures from the left mesial temporal lobe typically produce automatisms that correspond with the ictal disturbance. Other options (if provided) may list different auras or lateralizing signs, but the classic finding in this scenario is the presence of automatic behaviors tied to the affected temporal region. 1. An epigastric rising sensation is a common aura in MTLE. 2. Automatisms (especially orofacial) are a hallmark of temporal lobe seizures. 3. A detailed semiologic description is crucial for accurate localization. Recent guidelines emphasize early and accurate localization of the epileptogenic zone via EEG and imaging. There is ongoing research into improved pharmacologic treatments for MTLE; however, in drug\u2010resistant cases, surgical resection (e.g., anterior temporal lobectomy) remains the standard with excellent long\u2010term outcomes.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with MTS seizure on topamax 200mg BID and carbamazepine 400mg BID, his seizure still not controlled; what you will do?",
    "option_a": "increase Carbamazepine dose",
    "option_b": "refer to surgery.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "In mesial temporal lobe epilepsy caused by MTS, seizures often become drug\u2010resistant over time. When a patient fails to achieve seizure control with adequate trials of two appropriately chosen and dosed AEDs, the condition is classified as drug\u2010resistant epilepsy. MTS involves irreversible changes (neuronal loss and gliosis) in the hippocampus and related structures. This results in an epileptogenic network that continues to generate recurrent seizures despite medical therapy. The structural lesion often does not respond to dose adjustments alone. This patient, already on topiramate 200 mg BID and carbamazepine 400 mg BID, continues to have seizures. The failure of these two agents (provided they have been titrated to effective doses) meets criteria for drug-resistance, particularly in MTLE, where surgical outcomes are favorable. Evaluation includes a detailed seizure history, video EEG monitoring, and high-resolution MRI to document MTS. Differential diagnoses include non-epileptic events and other forms of focal epilepsy; however, the presence of MTS on imaging strongly supports MTLE. According to current guidelines (such as those from the ILAE), patients with drug-resistant MTLE should be referred for surgical evaluation. Options include anterior temporal lobectomy or selective amygdalohippocampectomy. In patients who are pregnant or planning pregnancy, surgical intervention (when indicated) may allow reduction in AED burden, thereby minimizing teratogenic risks; however, surgical risks and timing need to be carefully discussed. Option B \u2013 'Refer to surgery' is correct. Increasing the dose of carbamazepine (Option A) may not be effective if the patient has already failed an adequate trial with two AEDs. The surgical approach in MTLE with MTS has one of the highest success rates in curing or substantially reducing seizure frequency. 1. Drug resistance in MTLE is defined after failure of two appropriate AEDs. 2. Early surgical referral in drug-resistant epilepsy can significantly improve quality of life. 3. Comprehensive evaluation including video EEG and high-resolution MRI is essential. Recent studies and updated guidelines continue to support surgical treatment for drug-resistant MTLE as it offers the best chance for seizure freedom; advancements in minimally invasive surgical techniques have further improved outcomes and reduced complications.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Focal seizure treatment?",
    "option_a": "IV diazepam",
    "option_b": "IV keppra",
    "option_c": "IV phenytoin",
    "option_d": "IV depakin",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "Focal seizures, when presenting in an acute care setting (especially in the setting of status epilepticus), require prompt termination of the ictal event. Intravenous antiepileptic medications are used for rapid control. Focal seizures result from localized hyperexcitability of neurons. IV antiepileptics stabilize neuronal membranes and modulate ion channels, thereby curtailing the abnormal electrical discharges. Phenytoin accomplishes this by blocking voltage-dependent sodium channels. In an acute focal seizure scenario, after initial management with a benzodiazepine (if indicated), a longer-acting antiepileptic agent is administered to prevent seizure recurrence. IV phenytoin has long been a mainstay for this purpose, especially in older protocols and many emergency settings. The diagnosis is established clinically and by EEG for focal seizures. Differential diagnoses include generalized convulsive seizures or psychogenic non-epileptic events, which are differentiated by semiology and imaging studies. Current guidelines for the acute management of status epilepticus recommend an initial benzodiazepine followed by a second-line agent. IV phenytoin (or its prodrug, fosphenytoin) is a traditional second-line option. However, recent evidence supports the efficacy of IV levetiracetam (Keppra) and IV valproate (Depakine) as alternative options with comparatively favorable side effect profiles. In pregnancy, caution is advised with phenytoin due to teratogen concerns; levetiracetam may be preferred if available, and in lactation, phenytoin is considered relatively safe though monitoring is recommended. Option A (IV diazepam) is generally used as immediate seizure termination but is short-acting. Option B (IV Keppra) is an emerging alternative with good safety data. Option C (IV phenytoin) is the traditional, well\u2010established treatment and thus is the marked answer. Option D (IV Depakine/valproate) is also used but has a higher risk profile in women of childbearing age due to its teratogenicity. 1. In status epilepticus, always follow benzodiazepine administration with a longer acting AED. 2. IV phenytoin remains a cornerstone in the acute management of focal seizures in many protocols. 3. Consider patient-specific risk factors (especially in pregnancy) when selecting a second-line agent. Recent research suggests that IV levetiracetam may be as effective as IV phenytoin with fewer side effects, but many emergency protocols continue to utilize phenytoin (or fosphenytoin) as a standard treatment. Ongoing studies are focused on head-to-head comparisons to optimize safety and efficacy profiles in various patient populations.",
    "exam_year": "2021",
    "exam_type": "Part II"
  }
]